Skip to main
UNH

UnitedHealth Group (UNH) Stock Forecast & Price Target

UnitedHealth Group (UNH) Analyst Ratings

Based on 24 analyst ratings
Buy
Strong Buy 25%
Buy 54%
Hold 13%
Sell 8%
Strong Sell 0%

Bulls say

UnitedHealth Group demonstrates a strong growth outlook, with overall earnings anticipated to increase by 13% in 2026, largely driven by margin enhancements in the Medicare and commercial segments. The Optum sector, which complements the company's core managed care operations, is projected to see earnings growth across its various segments, with Optum Health expected to grow by approximately 9% and overall Optum earnings anticipated to rise between low and high single digits. Additionally, improved profitability metrics, such as a forecasted expansion of Medicare operating margins from 2.3% in 2025 to 3.0% in 2026, further solidify the company's robust financial position and competitive advantage in the healthcare industry.

Bears say

UnitedHealth Group is anticipating a notable decline in membership, with projections indicating a drop of 1.3 to 1.4 million members in 2026, primarily driven by losses in the Marketplace segment and increased plan shopping among Medicare Advantage members. Additionally, the company expects a deterioration in Medicaid margins, with estimates predicting a fall from -0.1% in 2025 to -1.8% in 2026, linked to the consequences of new Medicaid work requirements that will impact approximately 300,000 lives. Compounding these challenges, proposed 2027 Medicare Advantage rate adjustments are substantially lower than expected, reflecting broader industry concerns about stagnant rates relative to inflation and heightened utilization.

UnitedHealth Group (UNH) has been analyzed by 24 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 54% recommend Buy, 13% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of UnitedHealth Group and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About UnitedHealth Group (UNH) Forecast

Analysts have given UnitedHealth Group (UNH) a Buy based on their latest research and market trends.

According to 24 analysts, UnitedHealth Group (UNH) has a Buy consensus rating as of Mar 25, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $373.12, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $373.12, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

UnitedHealth Group (UNH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.